Thrombogenesis in mitral regurgitation and aortic stenosis

Area of Science:

• Cardiology
• Hematology
• Thrombosis Research

Background:

• Thrombus formation mechanisms in valvular heart disease (VHD) are not fully understood.
• Prothrombotic states, indicated by coagulation factor abnormalities, may contribute to stroke risk in VHD.
• Valvular heart disease presents a significant risk for thromboembolic events.

Purpose of the Study:

• To investigate the impact of mitral regurgitation (MR) and aortic stenosis (AS) on plasma fibrinogen and fibrin D-dimer levels.
• To assess MR and AS as indicators of a thrombogenic or prothrombotic state.
• To elucidate the relationship between specific VHD types and markers of coagulation.

Main Methods:

• Studied 25 patients with VHD in sinus rhythm: 12 with MR and 13 with AS.
• Measured plasma fibrinogen and fibrin D-dimer levels in patients.
• Compared patient levels to established population control values.

Main Results:

• Patients with MR showed significantly elevated plasma fibrinogen compared to population controls (P=0.0016).
• Patients with AS also demonstrated significantly increased plasma fibrinogen versus controls (P=0.001).
• MR patients had lower plasma fibrin D-dimer (P=0.05), while AS patients had similar levels to controls (P=0.80).

Conclusions:

• Both MR and AS are associated with elevated plasma fibrinogen, suggesting hemorheologic abnormalities.
• Lower fibrin D-dimer in MR patients indicates reduced intravascular clotting.
• Similar fibrin D-dimer levels in AS patients suggest distinct pathophysiological mechanisms for thromboembolism in this condition.